Search
Sagimet Biosciences Inc
SGMTAdd to Watchlist
10.220USD
-0.710-6.50%
Close 11-13 16:00（ET）
720.82MMarket Cap
LossP/E TTM
Sagimet Biosciences Inc (SGMT) Stock Price Target & Forecast
Analyst Rating
Based on 13 analysts giving stock ratings to Sagimet Biosciences Inc in the past month.
Buy
4 Strong Buy
8 Buy
0 Hold
1 Sell
0 Strong Sell
Target Price
27.917USD+181.42%
SGMT Analyst Recommendation Trends
In the current month, SGMT has received 8 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. SGMT average Analyst price target in the last month is 27.917.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
4
4
4
4
4
4
4
4
8
8
7
7
7
7
7
7
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
13
13
12
12
12
12
12
12
SGMT Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, SGMT EPS is projected to reach -0.289 in FY2026Q4, following reported EPS of -0.307 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.37
-0.25
-0.26
-0.29
-0.31
Actual
-0.33
-0.26
-0.31
--
--
Surprise
+12.61%
-6.70%
-18.26%
--
--
FAQs
What is Sagimet Biosciences Inc's price target?
Analysts forecast that Sagimet Biosciences Inc's price target is USD 27.92, with the highest forecast at USD 56.00 and the lowest forecast at USD 7.00.
How have Sagimet Biosciences IncSGMT's recent earnings per share performed?
The market expectation was USD -0.31, while Sagimet Biosciences IncSGMT's earnings per share (EPS) for the previous quarter was USD -0.26. EPS for the next quarter is expected at USD -0.29.
What is the analyst rating for Sagimet Biosciences Inc?
Based on the ratings of Sagimet Biosciences Inc's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.